# Explorative Phase II Study of Perioperative Treatment in Patients With Adenocarcinoma of the Gastroesophageal Junction or Stomach

> **NCT01472029** · PHASE2 · COMPLETED · sponsor: **AIO-Studien-gGmbH** · enrollment: 53 (actual)

## Conditions studied

- Adenocarcinoma of the Gastroesophageal Junction
- Adenocarcinoma of the Stomach

## Interventions

- **DRUG:** 5-FU, leucovorin, docetaxel, oxaliplatin (FLOT), trastuzumab
- **DRUG:** Post-operative treatment trastuzumab mono therapy

## Key facts

- **NCT ID:** NCT01472029
- **Lead sponsor:** AIO-Studien-gGmbH
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12
- **Primary completion:** 2014-08-25
- **Final completion:** 2016-09-12
- **Target enrollment:** 53 (ACTUAL)
- **Last updated:** 2017-06-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01472029

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01472029, "Explorative Phase II Study of Perioperative Treatment in Patients With Adenocarcinoma of the Gastroesophageal Junction or Stomach". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01472029. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*